{"title":"Neurofibromatosis 1 Presence in Breast Tissue: Case Report","authors":"Samuel Lichtman-Mikol","doi":"10.31579/2642-9756/113","DOIUrl":null,"url":null,"abstract":"Neurofibromatosis 1, also known as Von Recklinghausen disease, is the most common of the three neurofibromatoses. It is a multi-organ disease that is characterized by the development of cutaneous neurofibromas, plexiform neurofibromas, optic nerve gliomas, astrocytomas, Lisch nodules, and pheochromocytomas. We present a case of 66-year-old woman with NF-1. The disease presents with multiple cutaneous neurofibromas in both breasts. People living with NF-1 disease might have a different course of malignancy or other associated symptoms than the average individual without NF-1. It is essential that patients presenting with NF-1 symptoms are followed longitudinally to ensure that the progression of their symptoms are appropriately treated.","PeriodicalId":93058,"journal":{"name":"Women health care and issues","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Women health care and issues","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31579/2642-9756/113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Neurofibromatosis 1, also known as Von Recklinghausen disease, is the most common of the three neurofibromatoses. It is a multi-organ disease that is characterized by the development of cutaneous neurofibromas, plexiform neurofibromas, optic nerve gliomas, astrocytomas, Lisch nodules, and pheochromocytomas. We present a case of 66-year-old woman with NF-1. The disease presents with multiple cutaneous neurofibromas in both breasts. People living with NF-1 disease might have a different course of malignancy or other associated symptoms than the average individual without NF-1. It is essential that patients presenting with NF-1 symptoms are followed longitudinally to ensure that the progression of their symptoms are appropriately treated.